Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
QuidelOrtho ( (QDEL) ) just unveiled an update.
On August 21, 2025, QuidelOrtho Corporation completed a significant debt refinancing transaction, entering into a Credit Agreement with Bank of America and other lenders. This agreement includes a $1.15 billion senior secured term loan A, a $100 million delayed draw term loan A, a $1.45 billion senior secured term loan B, and a $700 million revolving credit facility. The refinancing allows QuidelOrtho to extend its debt maturities, reduce required amortization payments, and improve financial flexibility, supporting future growth and strengthening its capital structure.
The most recent analyst rating on (QDEL) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on QuidelOrtho stock, see the QDEL Stock Forecast page.
Spark’s Take on QDEL Stock
According to Spark, TipRanks’ AI Analyst, QDEL is a Neutral.
QuidelOrtho’s overall stock score is primarily influenced by its financial performance and earnings call insights. While the company shows potential for recovery with improved debt management and cash flow, recent losses and a negative P/E ratio weigh heavily on its valuation. The technical analysis suggests a bearish trend, further impacting the score. Positive earnings call highlights, such as growth in key segments and improved profitability metrics, provide some optimism but are counterbalanced by revenue declines in North America and COVID segments.
To see Spark’s full report on QDEL stock, click here.
More about QuidelOrtho
QuidelOrtho Corporation is a global leader in in vitro diagnostics, offering innovative diagnostic technologies for point-of-care settings, clinical labs, and transfusion medicine. The company specializes in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, providing fast, accurate, and reliable diagnostics from home to hospital, lab to clinic.
Average Trading Volume: 1,456,878
Technical Sentiment Signal: Sell
Current Market Cap: $1.82B
For a thorough assessment of QDEL stock, go to TipRanks’ Stock Analysis page.